Evidence map›Paper›PMID 40124362›Full record

ArticleFrontiers in immunology2025

Case Report: A novel

Gabriel Emmanuel Arce-Estrada, Miguel Rodríguez-Morales, Selma Cecilia Scheffler-Mendoza, Marimar Sáez-de-Ocariz, Laura Berrón-Ruiz, Sara Elva Espinosa-Padilla, Francisco Alberto Contreras-Verduzco

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Clinical Significance of IKBKB Mutations:Saudi medical journal · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriel Emmanuel Arce-EstradaUnidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Mexico City, Mexico.
Miguel Rodríguez-MoralesDepartamento de Genética Humana, Instituto Nacional de Pediatría, Mexico City, Mexico.
Selma Cecilia Scheffler-MendozaServicio de Inmunología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Marimar Sáez-de-OcarizServicio de Dermatología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Laura Berrón-RuizUnidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Mexico City, Mexico.
Sara Elva Espinosa-PadillaUnidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Mexico City, Mexico.
Francisco Alberto Contreras-VerduzcoUnidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To describe a novel Material and methods: Observational case report and literature review. Results: A five-month-old girl from an endogamous Mexican population developed symptoms suggestive of Kawasaki disease which progressed to hemophagocytic syndrome. Discussion: Hypogammaglobulinemia, candidiasis and mycobacterial infections were common in most cases identified. Our case is unique in presenting with Kawasaki disease, hemophagocytic syndrome, and mycobacteria from skin, blood, and bone marrow. Conclusions: We identified a novel homozygous PV in the

Indexed as

I-kappa B KinaseLymphohistiocytosis, HemophagocyticMucocutaneous Lymph Node SyndromeMutationTuberculosisFemaleGenetic Predisposition to DiseaseHomozygoteHumansInfantMycobacterium bovisI-kappa B KinaseIKBKB protein, humanacral skin nodulesdisseminated tuberculosishemophagocytic syndromeIKBKBsplenic abscesses

Identifiers

PMID40124362
PMCPMC11925931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.